trial · primary record
DS-1103a
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 128 |
| Primary completion | 2031-02-28 |
| Primary endpoint | Number of Participants with Dose-limiting Toxicities (Dose Escalation) |
| Registry ID | NCT05765851 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:48.742Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05765851
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.